
Emcure Pharma to unveil oral Covid-19 drug in a week
The Hindu
Emcure Pharmaceuticals Ltd (EPL) said it has received an Emergency Use Authorisation (EUA) approval from the Drug Controller General of India for the introduction of Molnupiravir, an investigational o
Emcure Pharmaceuticals Ltd (EPL) said it has received an Emergency Use Authorisation (EUA) approval from the Drug Controller General of India for the introduction of Molnupiravir, an investigational oral anti-viral drug, for the treatment of mild COVID-19.
EPL plans to roll out the drug under the brand name Lizuvira in the Indian market.
“As the need for such a drug is imminent in the face of emerging challenges in COVID-19 treatment, EPL will endeavour to deliver Lizuvira (Molnupiravir) in a week’s time. A toll-free Helpline will be dedicated to help the doctors and patients access the product,” the company said in a statement.













